CATX
Perspective Therapeutics Inc.
2.50$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.1% | – | 75.7% | 109.5% | – | – | 181.3% | 252.8% | 370.8% | 2,351.2% | 1,481.6% | 1,390.1% | 987.3% | |
| 11.9% | – | 24.3% | -9.5% | -81.3% | -203.0% | -81.3% | -152.8% | -270.8% | -2,251.2% | -1,381.6% | 100.0% | -612.0% | |
| 270.7% | – | 1,939.5% | 2,292.9% | 3,259.6% | 5,505.6% | 3,078.3% | 4,197.9% | 9,731.6% | 76,567.4% | 26,639.5% | 26,597.5% | 23,240.3% | |
| 224.9% | – | 2,129.7% | 1,696.6% | 1,890.2% | 3,523.9% | 2,125.2% | 2,658.3% | 3,699.0% | 16,165.1% | 9,190.8% | 9,623.5% | 7,203.4% | |
| 557.3% | – | 3,556.9% | 3,992.0% | 5,049.9% | 19,223.9% | 4,968.6% | 8,136.6% | 13,059.8% | 92,632.6% | 35,830.3% | 36,221.0% | 30,243.8% | |
| -545.5% | – | -3,532.6% | -4,001.5% | -5,049.9% | -19,223.9% | -5,049.9% | -8,289.3% | -13,330.6% | -92,632.6% | -37,211.8% | -36,121.0% | -30,619.1% | |
| 1.3% | – | 5.1% | 8.9% | 18.7% | 31.2% | 18.7% | 41.0% | 31.1% | 148.8% | 138.2% | 87.7% | 74.6% | |
| -531.9% | – | -3,468.1% | -3,637.8% | -4,098.1% | -18,062.4% | -4,098.1% | -7,585.9% | -12,425.4% | -89,030.2% | -34,459.2% | -33,070.4% | -28,662.1% | |
| 13.3% | – | – | -18.8% | – | -896.2% | – | -723.1% | – | -1,844.2% | – | 242.0% | – | |
| -531.9% | – | -3,752.2% | -3,779.7% | -4,098.1% | -17,166.2% | -4,098.1% | -7,408.6% | -12,425.4% | -87,186.0% | -34,459.2% | -33,069.1% | -28,468.0% | |
| -518.7% | – | -3,456.9% | -3,892.0% | -3,898.1% | -17,785.5% | -4,868.6% | -7,292.1% | -12,023.4% | -86,530.2% | -35,730.3% | -32,982.7% | -28,412.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.